X842 Capsules

· Jiangsu Sinorda Biomedicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for X842 Capsules, covering 2025-07-23 to 2025-07-23. Get the full timeline:

Most recent: Clinical Trial Update: The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis [Phase 3]